Ltd Juvenescence serves as Executive at AgeX Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ltd Juvenescence has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 14, 2023 involved gifting 16,447,500 shares valued at $0.
Ltd Juvenescence currently holds 16,419,000 shares of AgeX Therapeutics, Inc. (AGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ltd Juvenescence has been a net neutral trader of AGE stock. They have purchased $0 and sold $0 worth of shares.
Ltd Juvenescence's most recent insider trade was on Mar 14, 2023, when they sold 16,447,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |